Douglas J Batdorff Appointed New Vice President of Kewaunee Scientific Manufacturing Operations

Douglas J Batdorff has joined Kewaunee Scientific Corporation the Company as Vice President of Manufacturing Operations.  Mr. Batdorff will have responsibility for all of Kewaunee’s domestic manufacturing operations.

Mr. Batdorff has a Bachelor of Science in Mechanical Engineering from Michigan State University and a Master of Science in Manufacturing Operations from Kettering University.  Mr. Batdorff has held various executive leadership positions throughout his career, most recently with Legacy Cabinets, Inc. as Chief Operations Officer.  Prior to Legacy Cabinets, he was the Director of Manufacturing for US Operations of Steelcase, having held various management positions within Steelcase prior to that position.

“I am very excited to have Doug join our management team,” said Thomas D. Hull III, President and Chief Executive Officer of Kewaunee Scientific.  “His diverse manufacturing background will help accelerate Kewaunee’s operational excellence journey as we invest in our capabilities to improve our competitiveness in the marketplace.”

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”